Genetic polymorphism of N‐acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma
Authors:
- 9 September 2005
- journal article
- Published by Wiley in Head & Neck
- Vol. 27 (12) , 1056-1060
Abstract
Background.: The purpose of this study was to investigate whether polymorphism of N‐acetyltransferase 2 (NAT2) genotypes are associated with the risk of laryngeal squamous cell carcinoma (SCC).Methods.: The study group consisted of 45 white patients with laryngeal SCC (42 men, with a mean age of 54 years [range, 37–70 years] and three women, with a mean age of 47 years [range, 32–55 years]) and 104 control subjects (68 men and 36 women; mean age, 50 years; range, 28–73 years). All of the patients were primarily treated with surgical intervention. Blood samples (5 mL) were obtained before surgery or from the patients under follow‐up to 5 years after surgery (mean follow‐up, 27 months; range, 6–48 months). DNA was extracted from the lymphocytes by high pure template preparation kit. NAT2*5A, NAT2*6A, NAT2*7A/B, and NAT2*14A were detected by use of LightCycler‐NAT2 mutation detection kit by real‐time polymerase chain reaction with Light Cycler instruments. The association between NAT2 polymorphisms and laryngeal SCC was prospectively modeled through multivariate logistic regression analysis.Results.: We found that the risk of laryngeal SCC was 7.3‐fold higher in individuals with NAT2*5 mutant allele, 3.8‐fold higher in subjects with NAT2*6 heterozygote allele, and 38.3‐fold higher in NAT2*6 mutant allele. We also found that individuals with NAT2*7 heterozygote allele had a 0.2‐fold less risk for the development of laryngeal SCC (p = .018).Conclusion.: In this population, patients with NAT2*5 mutant and *6 heterozygous and mutant genotypes had a significantly higher risk for development of laryngeal SCC. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005Keywords
This publication has 21 references indexed in Scilit:
- Polymorphisms of Arylamine N-Acetyltransferase (NAT1 and NAT2) and Larynx Cancer SusceptibilityORL, 2002
- The Association Between Glutathione S‐Transferase P1 Genotype and Plasma Level in Head and Neck CancerThe Laryngoscope, 2002
- Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumoursCytogenetic and Genome Research, 1997
- Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynxThe American Journal of Surgery, 1996
- Glutathione S-transferase genotypes as risk factors for head and neck cancerThe American Journal of Surgery, 1995
- The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1993
- Structural Heterogeneity of Caucasian N-Acetyltransferase at the NAT1 Gene LocusArchives of Biochemistry and Biophysics, 1993
- Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesCarcinogenesis, 1993
- Acetyltransferases and susceptibility to chemicalsToxicology Letters, 1992
- Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), in cigarette smoke condensateCarcinogenesis, 1991